Lung Cancer Clinical Trial
Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Summary
The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.
Eligibility Criteria
Inclusion Criteria:
All participants must be 18 years of age or older.
Patient participants must have Stage III, IV and/or recurrent NSCLC.
Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
Patients must have working email address and internet access
Exclusion Criteria:
Any participant who cannot understand written or spoken English.
Any participant who is not competent to provide informed consent for study participation per the investigator.
Any participant who cannot be present for the related study visits and/or complete the post-test assessment
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19104, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.